The Race to Reinvent Antibiotics: Why Innovation and Access Must Go Hand in Hand
Register to Download PPT and View Why Innovation and Access Must Go Hand in Hand
April 9, 2025
by Neeta Ratanghayra
WHO's Newest Updates in Pharmaceutical GMP Guidelines
GMP is a fundamental concept in pharmaceutical manufacturing and distribution. Poor-quality medicinal products can lead to adverse effects, treatment failure, and even death. Implementing GMP assures that pharmaceutical products are produced with the high
April 23, 2024
by Saher Binte Haider
WHO Publishes Updated List of COVID-19 Medicines, APIs
The coronavirus disease 2019 (COVID-19) infections and deaths continue to be reported across the globe creating demand for more appropriate medicines and associated active pharmaceutical ingredients.
May 5, 2023
by SHEM OIRERE
WHO Prequalifies Ethionamide for Indian firm
The World Health Organization (WHO) in early April 2023 pre-qualified ethionamide, manufactured by Indian pharmaceutical company, Micro Labs Limited.
May 4, 2023
by SHEM OIRERE
How Africa, Asia could benefit from Ticagrelor’s WHO listing
Anglo-Swedish multinational pharmaceutical and biotechnology company, AstraZeneca Plc, has recently applied to World Health Organization for the inclusion of Ticagrelor.
April 19, 2023
by SHEM OIRERE
WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased
If COVID-19 vaccines and medicines are shared equally worldwide, the pandemic could ease this year, a top World Health Organization official said Tuesday.
January 19, 2022
by drugs.com
WHO recommends two new drugs to treat patients with COVID-19
The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe or critical COVID-19 in combination with corticosteroids...
January 18, 2022
by WorldPharmaNews
WHO recommends GSK-Vir and Lilly’s drugs for Covid-19 treatment
The World Health Organization (WHO) has recommended the use of two new drugs by GlaxoSmithKline (GSK) and Vir Biotechnology and Eli Lilly to treat Covid-19.
January 17, 2022
by Pharmaceutical-Technology
WHO recommends two new drugs to treat COVID-19
The extent to which these medicines, Baricitinib and Sotrovimab, will save lives depends on how widely available and affordable they will be...
January 17, 2022
by ExpressPharma
WHO body says COVID-19 vaccines ‘may need to be updated’ for Omicron
The technical group, made up of independent experts, said it would consider a change in vaccination composition and stressed that shots needed to be more effective in protecting against infection.
January 13, 2022
by ExpressPharma
World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the World Health Organization...
December 22, 2021
by prnasia
Sputnik V due to submit vaccine data to WHO this month
Moscow rushed to approve the shot for domestic use last year and it has been exported to countries around the world, but it has still not been certified by either the WHO or the EMA...
December 22, 2021
by expresspharma